PERTUZUMAB

pertuzumab 420 mg/14 mL injection, 14 mL vial

PERTUZUMAB (15386T)

pertuzumab 420 mg/14 mL injection, 14 mL vial
15386T
Body System:
Manner of administration:Injection
Public
Chemotherapy Items for Public Hospital use
Authority Required

Restriction

Indication: Early HER2 positive breast cancer
Treatment phase: Initial treatment
Quantities & Cost
Max amount # of repeats DPMA Max safety net General Patient Charge
Max amount: 840 mg # of repeats: 0 DPMA: $5,638.18 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Perjeta
(pertuzumab 420 mg/14 mL injection, 14 mL vial)